Manjunath Pai

Professor and Chair

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Karen Farris

University of Michigan

UNITED STATES

View details

Kathleen Stringer

Professor

University of Michigan

UNITED STATES

View details

Duxin Sun

UNITED STATES

View details

Marc Scheetz

Professor of Pharmacy Practice and Pharmacology

Midwestern University

UNITED STATES

View details

John C Magee

University of Michigan

UNITED STATES

View details

Katie B. Olney

UNITED STATES

View details

Athena Zuppa

Associate Professor

UNITED STATES

View details

Sriram Chandrasekaran

Assistant Professor

University of Michigan

UNITED STATES

View details

Jeong M. Park

UNITED STATES

View details

Federico Pea

Full Professor of Pharmacology

University of Bologna

ITALY

View details

N Lynn Henry

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manjunath Pai

Research Interests

Explore related searches

Contact this professor

Articles (20)

Bioanalysis of Six Antibiotics from Volumetric Microsamples: A New Tool for Precision Dosing in Critically ill Children

Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?

An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients

Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections

Clinical validation of two volumetric absorptive microsampling devices to support home‐based therapeutic drug monitoring of immunosuppression

Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections

Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales

Revolutionizing Daptomycin Dosing: A Single 7–11-Hour Sample for Pragmatic Application

Reconsideration of the Current Models of Estimated Kidney Function‐based Drug Dose Adjustment in Older Adults: The Role of Biological Age

Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug–Drug Interaction Pathway

Estimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs. serum creatinine

Removing race and body surface area indexation for estimated kidney function based drug dosing: Aminoglycosides as justification of these principles

A Comprehensive Mixed‐Method Approach to Characterize the Source of Diurnal Tacrolimus Exposure Variability in Children: Systematic Review, Meta‐analysis, and Application to an Existing Data Set

Kidney function as a key driver of the pharmacokinetic response to high‐dose L‐carnitine in septic shock

Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression

Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing

Medication Use Among U.S. Adults After Bariatric Surgery: A Population-Based Analysis of NHANES 2015–2018

Translation of Pharmacodynamic Biomarkers of Antibiotic Efficacy in Specific Populations to Optimize Doses

Pharmacokinetics of Polymyxin B in Hospitalized Adults with Cystic Fibrosis

Safety and efficacy of omadacycline by body mass index in patients with community-acquired bacterial pneumonia: Subanalysis from a randomized controlled trial

Collaborators (11)

Karen Farris

Kathleen Stringer

Duxin Sun

Marc Scheetz

John C Magee

Katie B. Olney

Athena Zuppa

Sriram Chandrasekaran

Jeong M. Park

Federico Pea

N Lynn Henry

Make your next move.